IGFBPI anticorps (AA 26-272)
Aperçu rapide pour IGFBPI anticorps (AA 26-272) (ABIN7177317)
Antigène
Voir toutes IGFBPI AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 26-272
-
Réactivité croisée
- Humain, Souris
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Mouse Insulin-like growth factor-binding protein 1 protein (26-272AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:1000-1:5000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IGFBPI (Insulin-Like Growth Factor Binding Protein 1 (IGFBPI))
-
Autre désignation
- Igfbp1
-
Sujet
-
Background: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Promotes cell migration (By similarity).
Aliases: Igfbp1 antibody, Igfbp-1 antibody, Insulin-like growth factor-binding protein 1 antibody, IBP-1 antibody, IGF-binding protein 1 antibody, IGFBP-1 antibody
-
UniProt
- P47876
-
Pathways
- Myometrial Relaxation and Contraction, ER-Nucleus Signaling, Growth Factor Binding
Antigène
-